EVAX

EVAX

USD

Evaxion Biotech A/S American Depositary Share

$5.600+0.030 (0.539%)

Echtzeitkurs

Healthcare
Biotechnologie
Dänemark

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$5.570

Hoch

$6.010

Tief

$5.570

Volumen

0.09M

Unternehmensfundamentaldaten

Marktkapitalisierung

44.4M

Branche

Biotechnologie

Land

Denmark

Handelsstatistiken

Durchschnittliches Volumen

1.59M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.2Aktuell $5.600Hoch $13.8

Ähnliche Nachrichten

GlobeNewswire

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for

Mehr anzeigen
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
GlobeNewswire

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a

Mehr anzeigen
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
GlobeNewswire

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report

Mehr anzeigen
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.